02/12/2026 | Press release | Archived content
March 9-12, 2026
Are you heading to HIMSS26? We'd love the chance to connect with you and share how Canary Speech is driving innovation in healthcare!
Catch the Canary team at our partner's booths including at:
Can't make it to HIMSS? No problem! Schedule 1:1 time to discuss how Canary fits into your business goals. Schedule time here.
Canary Speech is strengthening its commitment to responsible, transparent AI.
In a rapidly evolving AI landscape, CHAI brings clarity, accountability, and shared standards to ensure healthcare technologies are developed and deployed the right way. As a CHAI member, Canary actively collaborates alongside leading health systems, policymakers, and innovators to shape best practices for responsible AI.
Want to learn more?
Canary Speech has partnered with Intermountain Ventures and Intermountain Health to launch the first IRB-approved study exploring whether vocal biomarkers can help identify Multiple Sclerosis (MS). Led by neurologist Dr. Timothy West, the research will analyze voice samples to determine if AI-driven speech patterns can detect early indicators of the disease. With MS affecting more than 2.9 million people worldwide, this study could pave the way for faster, non-invasive screening and earlier intervention.
Read more about the study here.